Thyrocare Technologies Limited — Regulatory Filings 2021

Mar 6, 2021

==> picture [51 x 325] intentionally omitted <==

==> picture [35 x 464] intentionally omitted <==

ocare[y] Thyr

The Trust. The Truth.

March 06, 2021

To, National Stock Exchange of India Limited Exchange Plaza Sandra Kurla Complex, Sandra (E), Mumbai - 400 051

BSE Limited Phiroze Jeejeeboy Towers Dalal Street, Mumbai- 400 00 I

Dear Sir/Madam,

Sub: Disclosure of information under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Con- Call

--0--

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 20 I 5, this is to inform you that the representatives of First State Sentier would be having a Con-call (Zoom) with us, at 09.00 A.M. on Monday, March 08, 2021.

Please note that this is subject to any last minute changes.

Yours Faithfully,

For Thyrocare Technologies Limited,

==> picture [82 x 82] intentionally omitted <==

==> picture [82 x 40] intentionally omitted <==

Ramjee Dorai Company Secretary and Compliance Officer

Thyrocare Technologies limited

� enquiry@thyrocare.com (i www.thyrocare.com 9 D-37/1, TTC MIDC, Turbhe, Navi Mumbai - 400 703, India (9 022- 3090 0000 / 4125 2525

(CIN : L85110MH2000PLC123882)